Last updated: September 26, 2024
Sponsor: Nemours Children's Clinic
Overall Status: Active - Recruiting
Phase
N/A
Condition
Growth Hormone Deficiencies/abnormalities
Severe Short Stature
Holoprosencephaly
Treatment
N/AClinical Study ID
NCT04569149
MB001
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Individuals with MOPDII, MOPDI/III, Meier-Gorlin syndrome, or unclassified orclosely related types of microcephalic primordial dwarfism as diagnosed by a medicalprovider are eligible for this registry.
Exclusion
Exclusion Criteria:
- individuals without microcephalic primordial dwarfism or closely related conditions
Study Design
Total Participants: 150
Study Start date:
March 11, 2008
Estimated Completion Date:
January 01, 2030
Study Description
Connect with a study center
Nemours
Wilmington, Delaware 19803
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.